Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Published 13/11/2023, 13:32
Updated 13/11/2023, 14:40
© Reuters.  HP To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday

Benzinga - by Lisa Levin, Benzinga Editor.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page

  • Citigroup raised HP Inc. (NYSE: HPQ) price target from $31 to $33. Citigroup analyst Asiya Merchant upgraded the stock from Neutral to Buy. HP shares rose 2.2% to close at $27.62 on Friday. See how other analysts view this stock.
  • UBS increased the price target for Noah Holdings Limited (NYSE: NOAH) from $16.3 to $18. UBS analyst Helen Li upgraded the stock from Neutral to Buy. Noah Holdings shares gained 1.6% to $11.57 in pre-market trading. See how other analysts view this stock.
  • Piper Sandler slashed Health Catalyst, Inc. (NASDAQ: HCAT) price target from $12 to $11. Piper Sandler analyst Jessica Tassan upgraded Health Catalyst from Neutral to Overweight. Health Catalyst shares gained 3.1% to $6.92 in pre-market trading. See how other analysts view this stock.
  • Keefe, Bruyette & Woods increased the price target for AXIS Capital Holdings Limited (NYSE: AXS) from $59 to $66. Keefe, Bruyette & Woods analyst Meyer Shields upgraded the stock from Market Perform to Outperform. AXIS Capital shares gained 0.9% to close at $53.82 on Friday. See how other analysts view this stock.
  • HC Wainwright & Co. cut the price target for Nouveau Monde Graphite Inc. (NYSE: NMG) from $9 to $8. HC Wainwright & Co. analyst Heiko Ihle maintained a Buy rating. Nouveau Monde Graphite shares gained 2.6% to $2.79 in pre-market trading. See how other analysts view this stock.
  • Wells Fargo cut Barings BDC, Inc. (NYSE: BBDC) price target from $9 to $8.5. Wells Fargo analyst Finian O'Shea downgraded the stock from Overweight to Equal-Weight. Barings BDC shares fell 1.6% to $8.80 in pre-market trading. See how other analysts view this stock.
  • B of A Securities cut Paramount Group, Inc. (NYSE: PGRE) price target from $5 to $4. B of A Securities analyst Camille Bonnel downgraded the stock from Neutral to Underperform. Paramount Group shares fell 3% to $4.27 in pre-market trading. See how other analysts view this stock.
  • Wells Fargo slashed the price target for Crescent Capital BDC, Inc. (NASDAQ: CCAP) from $16.5 to $16. Wells Fargo analyst Finian O'Shea downgraded the stock from Overweight to Equal-Weight. Crescent Capital BDC shares fell 1.4% to $16.78 in pre-market trading. See how other analysts view this stock.
  • Barclays cut Waters Corporation (NYSE: WAT) price target from $270 to $230. Barclays analyst Luke Sergott downgraded the stock from Equal-Weight to Underweight. Waters shares gained 1.1% to close at $255.92 on Friday. See how other analysts view this stock.
  • Goldman Sachs cut GoodRx Holdings, Inc. (NASDAQ: GDRX) price target from $7 to $6. Goldman Sachs analyst Eric Sheridan maintained a Neutral rating. GoodRx shares fell 1.7% to $4.71 in pre-market trading. See how other analysts view this stock.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: Tyson Foods, Henry Schein And 3 Stocks To Watch Heading Into Monday

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.